8801:TSEMitsui Fudosan Co., Ltd. Analysis
Data as of 2026-05-26 - not real-time
¥1,544.50
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
Mitsui Fudosan is trading at ¥1,544.5, well below its 20‑day (¥1,616) and 50‑day (¥1,698) simple moving averages, with a bearish MACD histogram and an RSI hovering around 40, indicating a short‑term downtrend and elevated 30‑day volatility of roughly 40%. The price sits above the identified support at ¥1,461.5 but faces a sizable resistance near ¥1,767.5, while volume is on an upward trend, suggesting continued market participation. Fundamentally, the stock appears attractive: its forward PE of ~15 is less than half the industry average of 32.7, and the price‑to‑book ratio of 1.28 signals a modest premium to net assets. A dividend yield of 2.43% with a payout ratio under 35% points to a sustainable income stream, and the consensus analyst rating is “buy” with a median target price around ¥2,120, implying upside potential of over 40%. However, the balance sheet is heavily leveraged, reflected by a debt‑to‑equity ratio exceeding 130% and negative free cash flow, which could constrain future growth. Despite these risks, the low beta (≈0.2) suggests limited sensitivity to broader market swings, and the current “Extreme Greed” market sentiment may further support price appreciation.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Bearish technical indicators (price below SMAs, negative MACD)
- Proximity to support level limiting downside
- High short‑term volatility
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- Significant valuation discount to industry peers
- Sustainable dividend yield and low payout ratio
- Increasing trading volume and bullish market sentiment
Long Term
> 3 yearsPositive
Model confidence: 7/10
Key Factors
- Stable cash‑flow generation from diversified real‑estate portfolio
- Low beta indicating defensive characteristics
- Long‑term upside potential reflected in analyst price targets
Key Metrics & Analysis
Financial Health
Profit Margin10.29%
P/E Ratio15.3
ROE8.17%
ROA2.49%
Debt/Equity136.86
P/B Ratio1.3
Op. Cash Flow¥145.3B
Free Cash Flow¥-170097246208
Industry P/E32.7
Technical Analysis
TrendBearish
RSI40.1
Support¥1,461.50
Resistance¥1,767.50
MA 20¥1,616.03
MA 50¥1,697.72
MA 200¥1,719.64
MACDBearish
VolumeIncreasing
Fear & Greed Index91.64
Valuation
Target Price¥2,191.82
Upside/Downside41.91%
GradeUndervalued
TypeValue
Dividend Yield2.43%
Risk Assessment
Beta0.19
Volatility39.73%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.